May 03, 2011 - AdvaCare is already a leading pharmaceutical provider to Africa, Asia, the Middle East and South America. Due to the malaria prone nature of many of these regions, AdvaCare has introduced a wide range of products to treat this epidemic. AdvaCare antimalarial products are introducing the latest treatments to combat malaria resistant strains that prove ineffective to traditional formulations. Our antimalarial product line spans various preparations including tablets, injections, and powder for suspensions to meet the increasing demands of our markets.
AdvaCare has recently introduced our new line of high quality, affordable malaria rapid test kits that can detect all strains of common malaria including plasmodium falciparum and plasmodium vivax in human whole blood, serum, or plasma. Our antimalarial test kit product line, AccuQuik, is already supplying governments in Africa, and is set to expand into the private market soon.
Besides our newest addition to our expanding antimalarial product line, AdvaCare offers the following treatments in malaria prone regions:
- Artemether + Lumefantrine Tablets
- Artemether Tablets
- Artesunate + Amodiaquine Tablets
- Artesunate + Sulfadoxine + Pyrimethamine Tablets
- Artesunate Tablets
- Artemisinin + Piperaquinne Tablets
- Chloroquine Phosphate Tablets
- Compound Dihydroartemisinin Tablets
- Dihydroartemisinin +Piperaquine Tablets
- Quinine Sulfate Tablets
- Sulfadoxine + Pyramethamine Tablets
- Artemether Injection
- Chloroquine Phosphate Injection
- Quinine Dihydrochloride Injection
- Artemether + Lumefantrine Powder for Suspension
- Dihydroartemisinin Powder for Suspension
All AdvaCare facilities are GMP approved and have all necessary documentation to enter various markets. Please contact us to pre-qualify to become an AdvaCare distributor or to inquire about any of these products.
AdvaCare's Antimalarial Product Line Expanded
May 03, 2011 - AdvaCare is already a leading pharmaceutical provider to Africa, Asia, the Middle East and South America. Due to the malaria prone nature of many of these regions, AdvaCare has introduced a wide range of products to treat this epidemic. AdvaCare antimalarial products are introducing the latest treatments to combat malaria resistant strains that prove ineffective to traditional formulations. Our antimalarial product line spans various preparations including tablets, injections, and powder for suspensions to meet the increasing demands of our markets.
AdvaCare has recently introduced our new line of high quality, affordable malaria rapid test kits that can detect all strains of common malaria including plasmodium falciparum and plasmodium vivax in human whole blood, serum, or plasma. Our antimalarial test kit product line, AccuQuik, is already supplying governments in Africa, and is set to expand into the private market soon.
Besides our newest addition to our expanding antimalarial product line, AdvaCare offers the following treatments in malaria prone regions:
- Artemether + Lumefantrine Tablets
- Artemether Tablets
- Artesunate + Amodiaquine Tablets
- Artesunate + Sulfadoxine + Pyrimethamine Tablets
- Artesunate Tablets
- Artemisinin + Piperaquinne Tablets
- Chloroquine Phosphate Tablets
- Compound Dihydroartemisinin Tablets
- Dihydroartemisinin +Piperaquine Tablets
- Quinine Sulfate Tablets
- Sulfadoxine + Pyramethamine Tablets
- Artemether Injection
- Chloroquine Phosphate Injection
- Quinine Dihydrochloride Injection
- Artemether + Lumefantrine Powder for Suspension
- Dihydroartemisinin Powder for Suspension
All AdvaCare facilities are GMP approved and have all necessary documentation to enter various markets. Please contact us to pre-qualify to become an AdvaCare distributor or to inquire about any of these products.
